Medications for Cardiovascular Diseases
55 results
Atorvastatin calcium (atorvastatin calcium)
(Atorvastatin Calcium)Northwind Pharmaceuticals
Usage: Atorvastatin calcium is indicated for reducing cardiovascular disease risk in adults with multiple risk factors, managing hyperlipidemia, and as an adjunct to diet for lowering elevated cholesterol and triglyceride levels in various conditions, including familial hypercholesterolemia. It should not be used for certain lipoprotein abnormalities.
Atorvastatin calcium (atorvastatin calcium)
(Atorvastatin Calcium)NuCare Pharmaceuticals,Inc.
Usage: Atorvastatin calcium is indicated for lowering cholesterol and triglycerides in patients with hyperlipidemia and for reducing cardiovascular risks in adults with or without coronary heart disease. It serves as an adjunct to diet for various dyslipidemias and in children with heterozygous familial hypercholesterolemia, when necessary.
Atorvastatin calcium (atorvastatin calcium)
(Atorvastatin Calcium)NuCare Pharmaceuticals,Inc.
Usage: Atorvastatin calcium is indicated for reducing cardiovascular disease risks in adults with multiple risk factors and hyperlipidemia. It serves as an adjunct to diet for lowering cholesterol and triglyceride levels in patients with various dyslipidemias, including familial hypercholesterolemia and mixed dyslipidemia.
Crestor (rosuvastatin calcium)
(Rosuvastatin calcium)AstraZeneca Pharmaceuticals LP
Usage: CRESTOR is indicated to reduce cardiovascular risk in adults without coronary heart disease and to lower LDL cholesterol in various conditions, including primary hyperlipidemia, heterozygous and homozygous familial hypercholesterolemia, primary dysbetalipoproteinemia, and hypertriglyceridemia, as an adjunct to diet and other therapies.
Ezallor sprinkle (rosuvastatin)
(ROSUVASTATIN)Sun Pharmaceutical Industries, Inc.
Usage: EZALLOR SPRINKLE is indicated to reduce the risk of major adverse cardiovascular events in at-risk adults, lower LDL cholesterol in various hyperlipidemia types, and treat primary dysbetalipoproteinemia and hypertriglyceridemia in adults. It can be used alone or with other LDL-lowering therapies for patients with familial hypercholesterolemia.
Glyxambi (empagliflozin and linagliptin)
(empagliflozin and linagliptin)Boehringer Ingelheim Pharmaceuticals, Inc.
Usage: GLYXAMBI is indicated as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes mellitus. It also reduces the risk of cardiovascular death in those with established cardiovascular disease. It is not suitable for type 1 diabetes or patients with certain renal conditions.
Invokamet (canagliflozin and metformin hydrochloride)
(canagliflozin and metformin hydrochloride)Janssen Pharmaceuticals, Inc.
Usage: INVOKAMET and INVOKAMET XR are indicated as an adjunct to diet and exercise for glycemic control in adults and pediatric patients (10 years and older) with type 2 diabetes mellitus. Canagliflozin, a component, reduces risks of major cardiovascular events and kidney disease in specific diabetes populations.
Invokana (canagliflozin)
(canagliflozin)Janssen Pharmaceuticals, Inc.
Usage: INVOKANA (canagliflozin) is indicated to improve glycemic control in adults and pediatric patients aged 10 and older with type 2 diabetes, reduce cardiovascular event risk in those with established cardiovascular disease, and decrease risks associated with diabetic nephropathy. It is not recommended for type 1 diabetes or severe renal impairment.
Jardiance (empagliflozin)
(Empagliflozin)Aphena Pharma Solutions - Tennessee, LLC
Usage: JARDIANCE is indicated for improving glycemic control in adults with type 2 diabetes mellitus as an adjunct to diet and exercise, and for reducing the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease. Not recommended for type 1 diabetes or diabetic ketoacidosis.
Liraglutide (liraglutide)
(liraglutide)Teva Pharmaceuticals USA, Inc.
Usage: Liraglutide is indicated for improving glycemic control in adults and pediatric patients (10 years and older) with type 2 diabetes, and reducing the risk of major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease. It is not for use in type 1 diabetes patients.